Skip to main content
Signal8

Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

$WWBPress releaseNov 16, 2026, 4:01 PM ETRead the release

Windward Bio closed its IPO of 11,838,234 common shares at $17.00 per share, including full exercise of the underwriters' option, with combined gross proceeds of approximately $251.2 million alongside a concurrent private placement. Sanofi Foreign Participations B.V. purchased 1,532,691 shares plus pre-funded warrants for 1,408,485 shares for $50.0 million in an unregistered private placement at the IPO price.

Key figures

Deal Value Usd
251200000
Offering Price
17
Shares Offered
11838234
Prefunded warrant shares
1408485
Private placement shares
1532691
Private placement proceeds
50000000
Underwriters option shares
1544117

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.